Arginetix's Series A - II Round

Arginetix raised a round of funding on September 21, 2009.

Arginetix is developing arginase inhibitors for vascular and pulmonary conditions. Merged with Immune Control Inc. to form Corridor Pharmaceuticals.…

Articles about Arginetix's Series A - II Round: